Yahoo Finance 
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Summary This reports provides a data-driven overview of the current and future competitive landscape in Aicardi-Goutieres Syndrome therapeutics. Synopsis
New York, July 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" - https://www.reportlinker.com/p06291084/?utm_source=GNW
- There will be more than 4,000 prevalent cases of AGS each in 2022 across the 16 countries covered in epidemiology forecast.
- No FDA-approved marketed drugs are available for AGS, only symptomatic treatment is indicated for disease management.
- The drug currently in late-stage clinical development targets tyrosine kinase.
- Non-commercial sponsors dominate clinical trial development in AGS.
- No deals involving companies developing AGS assets were seen over the past 10 years.
- No regulator filing or commercial launch is expected for AGS in the next 18 months.
Scope
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Sponsors and Geography
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Aicardi-Goutieres Syndrome market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Aicardi-Goutieres Syndrome market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Read the full report: https://www.reportlinker.com/p06291084/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
